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ARTICLE
Satb2 Haploinsufﬁciency Phenocopies 2q32-q33 Deletions,
whereas Loss Suggests a Fundamental Role in the Coordination
of Jaw Development
Olga Britanova,* Michael J. Depew,* Manuela Schwark, Bethan L. Thomas, Isabelle Miletich,
Paul Sharpe, and Victor Tarabykin†
The recent identiﬁcation of SATB2 as a candidate gene responsible for the craniofacial dysmorphologies associated with
deletions and translocations at 2q32-q33, one of only three regions of the genome for which haploinsufﬁciency has
been signiﬁcantly associated with isolated cleft palate, led us to investigate the in vivo functions of murine Satb2. We
ﬁnd that, similar to the way in which SATB2 is perceived to act in humans, craniofacial defects due to haploinsufﬁciency
of Satb2, including cleft palate (in ∼25% of cases), phenocopy those seen with 2q32-q33 deletions and translocations in
humans. Full functional loss of Satb2 results in ampliﬁcation of these defects and leads both to increased apoptosis in
the craniofacial mesenchyme where Satb2 is usually expressed and to changes in the pattern of expression of three genes
implicated in the regulation of craniofacial development in humans and mice: Pax9, Alx4, and Msx1. The Satb2-dosage
sensitivity in craniofacial development is conspicuous—along with its control of cell survival, pattern of expression, and
reversible functional modiﬁcation by SUMOylation, it suggests that Satb2/SATB2 function in craniofacial development
may prove to be more profound than has been anticipated previously. Because jaw development is Satb2-dosage sensitive,
the regulators of Satb2 expression and posttranslational modiﬁcation become of critical importance both ontogenetically
and evolutionarily, especially since such regulators plausibly play undetected roles in jaw and palate development and
in the etiology of craniofacial malformations.
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The acquisition of jaws, a landmark event in vertebrate
evolution, in large part potentiated the diversiﬁcation and
success of the vertebrates. The developmental system that
coordinates and patterns the craniofacial primordia that
give rise to jaws involves an intricate spatiotemporal series
of reciprocal inductive and responsive interactions among
the cephalic epithelia (both endodermal and ectodermal)
and the cranial neural crest and cephalicmesodermalmes-
enchyme.1–4 The coordinated regulation of these interac-
tions is critical both to the ontogenetic registration of the
jaws, including of the palate, and to the evolutionary elab-
oration of variable jaw morphologies and designs.5 The
importance and sensitivity to perturbation of this devel-
opmental system is reﬂected by the fact that one-third of
all human congenital malformations affect the head and
face and their developing primordia.6,7 For instance, or-
ofacial clefting, including cleft palate (CP) and/or cleft lip,
constitutes one of the most common human birth defects
(from 1 in 500 to 1 in 2,000 births, depending on the
population) and exhibits a notably complex etiology.8–12
Correlation of the genetic, molecular, and cellular mech-
anisms underlying the etiology of such malformations
lags, however, relative to the importance of the problem.
Cytogenetic evidence, based on interstitial deletions
and balanced translocations, has previously implicated
human 2q32-q33 (CPI [MIM 119540]) as a craniofacial
dysmorphology locus.13–15 Patients with 2q32-q33 dele-
tions are characterized by malformations, including long
(occasionally asymmetric) faces with small mouths, high
foreheads, cleft (or high-arched) palates, micrognathia,
maxillary hypoplasia, and short, broad teeth with large
diastemata.15 Similar dysmorphisms, including narrow
faces with prominent nasal bridges, small mouths, and
CP, are associatedwith balanced translocationswithbreak-
points in distal 2q32.14 Notably, 2q32-q33 is one of only
three regions of the genome for which haploinsufﬁciency
has been signiﬁcantly associated with isolated CP.13 Mod-
eling such haploinsufﬁciency in mice has proven difﬁ-
cult because somatic heterozygous mutations implicated
in CP in humans, such as mutations in MSX1 (MIM
142983), PAX9 (MIM 167416), and TBX1 (MIM 602054),
are known to lead to CP in only homozygous states in
mice.8,11,12,16–22
SATB2 (MIM 608148) has recently been identiﬁed as a
candidate CP gene at 2q32.10 SATB2 and murine Satb2 are
highly conserved (99.6%) members of a small, novel tran-
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scription-factor gene family whose members bind to nu-
clear matrix attachment regions and appear to be involved
in the regulation of the tissue-speciﬁc organization of
chromatin, thereby augmenting the potential for en-
hancers to act over large distances.10,23,24 Satb2 is, further-
more, a target for SUMOylation, a reversible modiﬁcation
of the protein that modulates its activity as a transcription
factor.24 Although exonic polymorphisms have yet to be
found in SATB2, a point mutation of SATB2 has recently
been identiﬁed in a large screen of patients with isolated
CP.25 Despite its recently identiﬁed association with CP
and 2q32-q33 deletions, direct tests of Satb2 functionhave
not been reported elsewhere.
To study the in vivo functions of Satb2, we generated a
Satb2 null allele through homologous recombination. In
line with the hemizygosity of SATB2 being implicated in
CP and the craniofacial malformations linked with 2q32-
q33 deletions in humans, we demonstrate similar gene-
dosage effects (haploinsufﬁciency) in the regulation of jaw
and palate development exerted by Satb2 in mice. Full
functional loss of Satb2, moreover, ampliﬁes the craniofa-
cial deﬁcits observed in Satb2 heterozygotes. Plausibly un-
derlying the mechanistic etiology of these deﬁcits, the loss
of Satb2 is associated with increased apoptosis in the
discrete, complementary regions of the developing jaw
primordia where it is expressed and with the subsequent
arrest of regional development, including the down-reg-
ulation of the expression of genes associated with crani-
ofacial development, such as Msx1, Alx4 (MIM 605420),
and Pax9.16–20,26,27 Coupled with its spatiotemporal ex-
pression proﬁle, this marks Satb2 as a potentially key gene
coordinating the elaboration of the functional design of
jaws, including of the mammalian palate.
Material and Methods
Targeted Disruption of Satb2
A Satb2 null allele was generated through homologous recom-
bination by elimination of the second exon in the protein-coding
region and replacement with a Cre recombinase–coding sequence
and a Neo expression cassette. Before designing the targeting vec-
tor, we detected several splice forms of Satb2 message by RT-PCR.
To rule out possible exon skipping for the ﬁrst coding exons, we
performed RT-PCR with several sets of primers speciﬁc to the ﬁrst
four coding exons (not shown). We were not able to make a ﬁrm
conclusion regarding skipping of the ﬁrst coding exon; however,
since the second coding exon was present in all RT-PCR products
(indicating that it is very unlikely to be the subject of exon skip-
ping), we targeted the second coding exon. The Satb2 construct,
along with G418 resistance selection, was electroporated into em-
bryonic stem (ES) cells, from which 150 positive colonies were
obtained. Recombinant colonies were identiﬁed by Southern-blot
analysis of NsiI-digested genomic DNA hybridized with a 3′ ex-
ternal probe designed to detect wild-type and mutant allele frag-
ments of 7.5 kb and 4.6 kb, respectively. Five of the 150 positive
ES colonies were selected. To conﬁrm the targeted insertion of
the construct into the genomic DNA of the positive colonies, we
used PCR ampliﬁcation with a primer set consisting of an internal
primer and a speciﬁc 5′ external primer.
Histology
Animals used for histology were ﬁxed in 4% paraformaldehyde
(PFA) in PBS, embedded in parafﬁn or optimum cutting temper-
ature compound, and then were cut into 8–20-mm-thick serial
sections. Sections were then prepared with nissel staining.
Differential Bone and Cartilage Staining and Relative
Mandibular Measurement
Differential staining of cartilage and bone was achieved through
the use of Alcian blue and Alizarin red as per Depew et al.4 Dif-
ferentially stained wild-type, heterozygous, and homozygous
neonatal dentaries were dissected, ﬂat mounted, and photo-
graphed en masse at the same magniﬁcation. Individual man-
dibular length was set against the same rule scale (0–110) and
was tabulated as the distance from the most proximal tip of the
secondary cartilage of the condylar process to the buccal surface
of the most distal tip of the ossiﬁed dentary proper. The mean
length ( ), SD, and population size were calculated and normal-
—
x
ized around an of 100 for the wild type.
—
x
Scanning Electron Microscopy
Embryos were taken from timed pregnancies and were ﬁxed at
4C overnight in 4% PFA in PBS. The embryos were then rinsed
three times in PBS and were dehydrated in an increasing series
of MeOH. They then were critical-point dried, were sputter coated
with gold paladium, and were photographed using an FEI Quanta
200F ﬁeld-emission scanning electron microscope.
In Situ Hybridization and Satb2 Immunohistochemistry
In situ hybridization was performed as described by Depew et al.4
and Britanova et al.,23 and Satb2 immunoreactivity as described
by Britanova et al.23
Apoptosis
Apoptotic cell death was assessed by TUNEL assay on parafﬁn
sections by use of the Apoptag Fluorescein Direct In situApoptosis
Detection Kit (Chemicon), in accordance with themanufacturer’s
instructions.
Results
Expression of Satb2
The identiﬁcation of SATB2 as a gene associated with CP
in humans led us to further clarify Satb2 expression and
function during craniofacial development. As anticipated,
Satb2 is expressed in the developing jaw primordia during
the pharyngula stages of murine development (ﬁg. 1). We
did not detect a strong signal by in situ hybridization be-
fore embryonic day 10 (E10); however, by E10.5 andE11.5,
Satb2 is expressed in a complementary fashion in themes-
enchyme at the junction of the maxillary ﬁrst branchial
arch (BA1) and the medial frontonasal process (FNP) and
in the distal mandibular BA1 that contributes to the upper
and lower jaws, respectively. These Satb2-expression do-
mains demarcate potential developingmoduleswithin the
overall jaw complex and are strategically placed to act in
the coordination of jaw registration. As has been reported
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Figure 1. Pharyngeal and early-morphogenetic-stage Satb2 expression. a–c, Satb2 expression detected through in situ hybridization
at E10.5 and E11.5 in the mesenchyme of the distal maxillary BA1 (mx), associated FNP (l p lateral; m p medial), and the distal
mandibular BA1 (md). Expression is associated with the distal regions but, signiﬁcantly, is excluded from the actual midlines (arrowheads).
op p olfactory pit. d, Radioactive in situ hybridization at E12.5, demonstrating Satb2 expression in the tongue (tg) and in the
developing lower (md) and upper (mx) jaws, including in the future palatal shelves (ps).
elsewhere, we ﬁnd that expression is regionally main-
tained during the morphogenetic stages of jaw develop-
ment (ﬁg. 1).
Craniofacial Defects Due to Haploinsufﬁciency of Satb2,
Which Phenocopy Those of Human 2q32-33 Deletions
We generated a Satb2 null allele through homologous re-
combination by eliminating the second exon in the pro-
tein-coding region (ﬁg. 2). Heterozygous mice are born
and are fertile but, notably, wean at a lower-than-expected
frequency (∼35%). In a C57Bl/6 background, the snout of
adult heterozygous animals is strongly truncated and oc-
casionally asymmetric. This, coupled with their lower-
than-expected frequency, led us to address the early course
of craniofacial morphogenesis in Satb2/ mice. Differ-
ential staining of bone and cartilage and histologic anal-
ysis of fetal and neonatal Satb2/ mice demonstrates the
early onset of these craniofacial dysmorphologies (ﬁg. 3).
With a striking phenotypic similarity to 2q32 deletions
and translocations, Satb2/ neonates exhibit slight mi-
crocephaly, small mouths, premaxillary and nasocapsular
hypoplasia, micrognathia, and variable incisor hypodon-
tia and/or adontia (ﬁg. 3b, 3e, 3h, and 3t). As an expla-
nation of their lower-than-expected frequency at weaning
and in line with SATB2 hemizygosity in humans, approx-
imately one in four perinatal heterozygotes examined
have CP (ﬁg. 3b). Signiﬁcantly, to our knowledge, our tar-
geted mutation of Satb2 provides the ﬁrst clear murine
haploinsufﬁciencymodel for the study of a knownhuman
haploinsufﬁcient CP genetic locus.
Satb2 Dosage Sensitivity in Jaw and Palate Development
Relative to Satb2 heterozygotes, homozygotes are born
(and die perinatally) with exacerbated skeletal malfor-
mations, including signiﬁcant micrognathia, increased
microcephaly, nasocapsular and premaxillary hypoplasia,
and fully penetrant incisor adontia and CP (ﬁg. 3c, 3f, 3i,
3q, and 3u). The jaw deﬁciencies of the Satb2/ mutants
are focal, with the mesenchymal component of the Satb2-
positive jawmodule having clearly failed to elaborate local
morphogenetic programs. Both the upper and lower jaws
are affected in comparable domains, reﬂective of the sym-
metrical, complementary regional patterns of Satb2 ex-
pression. Notably, the midline structures connected to the
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Figure 2. Design rationale for the targeted loss of Satb2. a, Schematic representation of the Satb2 locus, the targeting vector, and
the targeted locus. Coding exons are shown as unblackened boxes. Restriction sites are SmaI (S), NsiI (N), and PacI (P). Oligonucleotides
are indicated by arrows and are designated “a” and “b.” The expected fragments are indicated by the dashed red lines. The 3′ external
probe (purple box) identiﬁes a 7.5-kb NsiI fragment in the wild-type allele and a 4.6-kb fragment in the mutant allele. b, Analysis of
transfected ES cells (left) and wild-type (WT), heterozygous (/), and homozygous (/) mice (right) by genomic Southern-blot
analysis with a 3′ external probe. Mut p mutant allele. c and d, Immunohistochemical detection of Satb2 protein in E13.5 wild-type
(c) and Satb2/ (d) embryos. Satb2 immunoreactivity (arrowheads) is detected in the forming palatal shelves (ps) of the wild-type
embryo, whereas it is not detected in the craniofacial primordia of the Satb2/ embryo; however, possibly because of exon skipping,
some Satb2-positive cells are detected in the spinal cord of the Satb2/ embryo, just as they are in the wild-type embryo. nsp Nasal
septum; sc p spinal cord; tg p tongue.
upper and lower jaw arcades are patent, as evidenced by
the rostral process of Meckel’s cartilage (ﬁg. 3l–3o) in the
lower jaws and by the septal cartilages overlying the upper
jaws. Parasagittal elements, such as the incisors and their
associated alveolar bone, however, fail to form in each jaw
quadrant. Elements associated with the region of the ar-
ticulation of the jaws, such as the proximal dentary and
the squamosal, are unaffected (ﬁg. 3p and 3q). Effectively,
a lack of Satb2 results in the loss in each jaw quadrant of
complementary parasagittal structures, such as the inci-
sors, whose development needs to be coordinated, to keep
the jaws functionally in register. As seen in scanning elec-
tron micrographs, these focal losses of skeletal structures
in the Satb2/ mutants are clearly presaged by distinct
morphological abnormalities by E12 (ﬁg. 3j and 3k).
Additional defects, including shortened limbs, hyoid
malformations, and severe microglossia, are evident in the
Satb2/ mutants (ﬁg. 3 and data not shown). Oral epi-
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Figure 3. Satb2 gene-dosage sensitivity in craniofacial development. a–c, Differentially stained skulls of wild-type (wt), Satb2/,
and Satb2/ neonates demonstrating the effect of gene dosage on upper jaw and palatal (yellow arrowheads) development. White
arrows indicate hypoplasia of premaxillae (px) and nasal capsules. Green arrowhead (c) indicates the exacerbated deﬁciencies of nasal
capsules, primary palate, and upper incisors (compare with panel b). Red arrows (b and c) indicate the midline trabecular basal plate.
as p Alisphenoid; bs p basisphenoid; mx p maxilla; pg p pterygoid; psm p maxillary palatal shelf; psp p palatine palatal shelf;
psx p premaxillary palatal shelf; v p vomer. d–i, Comparative histological sections of nissel-stained wild-type, Satb2/, and Satb2/
 postnatal day 0 and E13.5 embryos, highlighting loss of parasagittal hard- and soft-tissue structures. Arrowheads: green p midline
nasal septum; peach p upper molar tooth or bud; turquoise p lower molar tooth or bud; red p body of Meckel’s cartilage; blue
outlined in yellow p midline of lower jaw and tongue; black outlined in green p developing palatal shelf; black outlined in red p
tongue; black outlined in yellow p developing submandibular gland; white p nasopharynx. j and k, Scanning electron micrographs
of wild-type and Satb2/ embryos at E12. Unblackened arrowheads indicate the midline, orange arrowheads highlight relativemandibular
hypoplasia, and arrows indicate maxillary and FNP deﬁcits (compare oral aperatures). l and m, Gross anatomy of wild-type and Satb2/
 E16 littermates demonstrating the small mouth, parasagittal hypoplasia, micrognathia, and maintenance of midline structures in
mutants. “a–e” indicate relative positions of lateral and mandibular sinus follicles. Arrows are as in panels j and k. n and o, Skulls of
the specimen in panels l and m, showing the speciﬁc loss of the distal portion of dentaries and distal juxtaposed portion of Meckel’s
cartilage (compare orange arrowheads) but the presence of the midline rostral process (unblackened arrowheads). This maintenance of
the midline of lower-jaw apparatus is mirrored in the upper jaws by the presence of the nasal septum and associated paraseptal cartilages
and vomeronasal organs but the absence of much of the premaxillae and associated nasal capsule and incisors. p and q, Microcephaly,
micrognathia (black arrowhead), premaxillary (px) hypoplasia (arrow), and absence of incisors in a neonatal Satb2/ skull seen in norma
lateralis (q) compared with a wild-type skull (p). Note the maintenance of the articular region (purple arrowheads). r, Labeled schema
of wild-type neonatal dentary indicating the orientation for measuring relative dentary length. agp p Angular process; 2agp p
secondary cartilage of agp; cdp p condylar process; 2cdp p secondary cartilage of cdp; crp p coronoid process; dnt p body of the
dentary; inap incisive alveolus; LIp lower incisor; moap molar alveolus; mtfp mental foramen; rpMCp rostral process of Meckel’s
cartilage. s–u, Measurements of neonatal wild-type, Satb2/, and Satb2/ littermates along with , SD, and population size (n) of—x
the measured population for which they are samples.
thelial derivatives are, moreover, variably affected—for in-
stance, molar dental buds are enlarged and contain elab-
orated epithelial folds, and submandibular glands fail to
develop (ﬁg. 3).
Early, but Not Late, Molecular Pattern Maintained in Satb2
Null Embryos
To address molecular and cellular mechanistic explana-
tions for the morphologic deﬁcits of the Satb2/mutants,
we ﬁrst assayed for changes at E10.5 in regionally ex-
pressed genes known to be regulators of jaw develop-
ment. As anticipated by the apparently relatively late on-
set of branchial arch Satb2 expression, at E10.5, the expres-
sion patterns of Dlx5 (MIM 600028), Msx1, Pitx1 (MIM
602149), Prx2 (MIM 604675), Barx1 (MIM 603260), and
dHAND (MIM 602407) are unchanged (ﬁg. 4a and 4b and
data not shown), suggesting that fundamental aspects of
the initial molecular pattern of the jaw primordia are ex-
tant in the Satb2/ mutant embryos. At later stages of
development, however, we detect subregional changes
in the expression of genes known to be associated with
jaw and palatal development in both humans and
mice,16–20,26,27 including that of Pax9 at E11.5 in the BA1
mesenchyme (ﬁg. 4c and 4d) and Alx4 and Msx1 at E13.5
in the base of the forming palate (ﬁg. 4g–4j). Thus, al-
though it is unclear whether these three genes are direct
targets of Satb2 protein, it is clear that Satb2 is required
for normal expression of genes critical to craniofacial
development.
Necessity of Satb2 for Cell Survival in Its Expression
Domains
The notable loss of gene expression at E11.5 and loss of
structure by E12, coupled with the maintenance of initial
molecular pattern at E10.5, strongly suggested that dif-
ferential cell survival and/or proliferation between these
time points underlay the phenotypic defects observed.We
therefore assayed for changes in the levels of apoptosis in
the developing jaw primordia at E11.5. A marked increase
in the number of apoptotic cells in the mandibular BA1,
maxillary BA1, and FNP in the regions normally express-
ing Satb2 was observed in Satb2/ mutant embryos rela-
tive to wild-type embryos (ﬁg. 5), thus providing a partial
mechanistic explanation for the subsequent morphoge-
netic deﬁcits found in the Satb2/ mutants. In line with
the more variable severity of the deﬁcits (ﬁg. 3r–3u), we
detected a more variable increase in apoptotic cells in the
Satb2/– embryos (data not shown).
Discussion
The identiﬁcation of SATB2 as a candidate gene respon-
sible for the craniofacial dysmorphologies associated with
2q32-q33 deletions and translocations led us to investigate
the in vivo functions of Satb2. By generating a Satb2 null
allele in mice through homologous recombination, we
have demonstrated that Satb2 acts in a dosage-dependant
manner, similar to the way in which SATB2 is perceived
to act in humans, as an essential regulator of murine jaw
and palate development and morphogenesis. Moreover,
Figure 4. Gene expression in Satb2/ mutants. a and b, In situ hybridization of Msx1 (a) and Dlx5 (b) in wild-type (wt) and
Satb2/ mutant E10.5 embryos indicating the presence of the initial molecular polarity in the developing branchial arches of
Satb2/ mutants. l p Lateral frontonasal process; m p medial frontonasal process; md p mandibular BA1; mx p maxillary BA1; op
p olfactory pit. c and d, Marked decrease of Pax9 expression at E11.5 in the mandibular incisor ﬁeld (if) of the mutant (red arrowhead)
presages the loss of the incisor developmental module. The white arrow indicates the midline. di p Diastema; mf p molar ﬁeld. e
and f, Serial histological sections of wild-type (e, g, and i) and Satb2/ mutant (f, h, and j) embryos at E13.5 highlight the nasal
capsular hypoplasia, microglossia, and loss of submandibular glands in the mutant and the subregional loss (compare red arrowheads)
of Alx4 (h) and Msx1 (j) expression within the base of the developing palate of the mutant. lm p Lower molar bud; MC p Meckel’s
cartilage; nc p nasal capsule; ns p nasal septum; oe p olfactory epithelium; ps p palatal shelf; smg p submandibular gland; tgp
tongue; um p upper molar bud.
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Figure 5. Increased cell death at E11.5 in Satb2/ mutants. Parasagittal (a and b) and coronal (c and d) sections of E11.5 wild-
type (a and c) and Satb2/ (b and d) embryos assayed for apoptosis (TUNEL) demonstrate focal increases in cell death in the mandibular
(md [red arrowheads]), maxillary (mx [yellow arrowheads]), and frontonasal (fnp [yellow arrowheads]) mesenchyme. White arrowheads
indicate the midline, green arrowheads indicate the lambdoidal junction, and purple arrowheads point to typical apoptosis found at
the maxillo-mandibular junction. fb p Forebrain; hrt p heart; hy p hyoid arch; op p olfactory pit.
its absence leads both to increased apoptosis in a highly
localized fashion in craniofacial mesenchyme and to
changes in the pattern of expression of three genes known
to regulate craniofacial development in humans and
mice—Pax9, Alx4, and Msx1.
While this manuscript was under review, another loss-
of-function investigation of Satb2 was published.28 In
many respects, such as the early maintenance of expres-
sion of a number of genes known to be essential for proper
craniofacial development, our analysis of the conse-
quences of the loss of Satb2 for craniofacial development
coincides with the analysis of Dobreva et al.28; however,
perhaps because of variance in targeting strategies, differ-
ences exist in several critical respects. For instance, al-
though the report of Dobreva et al.28 states that hetero-
zygous Satb2/ mice are phenotypically normal and
fertile, we ﬁnd signiﬁcant phenotypic defects due to Satb2
haploinsufﬁciency. This is notable with regard to human
pathogenicity, since 2q32-q33 is a locus signiﬁcantly
linked with craniofacial malformations and, importantly,
is one of only three regions of the genome for which hap-
loinsufﬁciency has been signiﬁcantly associated with iso-
lated CP.13 Our Satb2/ mice exhibit phenotypic similar-
ities corresponding to those seen with 2q32 deletions and
translocations in humans, including CP (in ∼25% of
cases), microcephaly, reduced oral aperture, hypoplasia of
the premaxillae and nasal capsules, lower jaw microgna-
thia, and variable incisor hypodontia and/or adontia.
Uniquely, our targeted mutation of Satb2 provides the ﬁrst
clear murine haploinsufﬁciency model for the study of a
known human haploinsufﬁcient CP genetic locus. Previ-
ously, modeling such haploinsufﬁciency in mice proved
difﬁcult because somatic heterozygous mutations impli-
cated in CP in humans (e.g., MSX1, TBX1, and PAX9) are
known to lead to CP in only homozygous states inmice.16–
22
Notably, the cleft or arched palate and microglossia as-
sociated with 2q32-q33 deletions may be correlated with
Pierre Robin sequence,29,30 a clinical phenotype character-
ized by micrognathia and CP with glossoptosis and often
considered to result from a series of causal events. Al-
though no single nosologic etiology represents Pierre
Robin sequence, Satb2 haploinsufﬁciency results in vari-
able cleft or arched palate, micrognathia, and microglos-
sia. Since cell death is regionally associated with the pri-
modia of the palate (in the maxillary arch) and that
portion of the mandibular ﬁrst arch that is associatedwith
the tongue, in this instance the phenotypic correlation of
Satb2 loss and Pierre Robin sequence is likely due to in-
dependent growth deﬁciencies.
A second signiﬁcant point of difference between our
analysis and that of Dobreva et al.28 involves the apparent
coordination of defects between the jaw primordia. Do-
breva et al. present important data regarding a role for
Figure 6. Modeling the signiﬁcance of Satb2 for coordination and elaboration of jaw development. a and b, Hemisected human (a)
and canine (b) skulls showing the nature of jaws as hinged, appositional mechanisms of which polarity and potential modularity are
characteristics. The translucent circle around the jaw articulation represents the hinge as a region, whereas the blue arrows highlight
the polarity generated by the position of the hinge. The potential for modularity inherent in polarized structures is depicted by the
relative purple shading of the jaws. c, Functional demands, such as for the matched occlusion of the homodont dentition of the jaws
of the Ganges River dolphin (Platanista gangetica), dictate that jaw registration must be ontogenetically coordinated. The lower jaw
is lavender to better differentiate the jaws. d and e, Diagrams of E10.5 murine embryos, highlighting the integration of some of the
signaling centers believed to act in setting pattern, polarity, and modularity in the developing jaw primordia. The translucent circle
represents the presumptive hinge region, whereas the blue arrows indicate positional information, such as Fgf expression, emanating
from the ﬁrst pharyngeal plate and the oral ectoderm at the junction of the maxillary (mxBA1) and mandibular (mdBA1) ﬁrst arch in
this region. This positional information is integrated with midline signaling sources coming from the distal midline mdBA1 and the
lambdoidal junction (l), where mxBA1 meets the medial (mFNP) and lateral (lFNP) frontonasal processes. The relative purple shading
signiﬁes the polarity and potential modularity of the primorida set up by this integration. The orange arrowhead indicates the mdBA1
midline, whereas the blue discs indicate the relative positions of Satb2 expression in the left-side upper- and lower-jaw primordia.
Modiﬁed from Depew et al.4 f, Diagram integrating pattern, polarity, and modularity between embryonic and adult jaws. The disc
represents the articulation of the upper and lower jaws, whereas the arrows represent the integrated signaling from the hinge region
(blue) and distal ends (red). Polarity and modularity are marked by the toothed modules differentially shaded in purple. g–i, Three (of
many) hypothetical scenarios for the modiﬁcation of jaw modules through the differential regulation of Satb2 activity. Although it is
assumed that the default state lies with the equivalence of each complementary module, the functional demands of any particular
organism may require the modiﬁcation of one or more complementary modules. This can occur by altering Satb2 activity at multiple
levels, including both transcriptionally and posttranscriptionally. g, Scenario one: simultaneous down-regulation (red bars) of Satb2
activity in the blue modules of both the upper and lower jaws may result in either the diminution of growth of these modules (top
arrow) or the loss of these modules (bottom arrow), a scenario essentially examined in our targeted loss of Satb2. h, Scenario two:
speciﬁc down-regulation (red bars) of Satb2 activity in the upper-jaw blue module, its up-regulation (green arrow) in the lower jaw, or
both may result in relative lengthening of the lower jaw, such as seen in the mastodon, Phiomia. Modiﬁed from Romer after Andrews.31
i, Scenario three: speciﬁc up-regulation (green arrow) of Satb2 activity in the upper-jaw blue module, its down-regulation (red bars)
in the lower jaw, or both may result in relative lengthening of the upper jaw, such as seen in the thecodont, Chasmatosaurus. Modiﬁed
from Romer.32
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Satb2 in osteogenesis. This includes data indicating an in-
teraction during calvarial osteogenesis between Satb2 and
Hoxa2 (MIM 604685), a gene that is not normally ex-
pressed in the jaw forming BA1 and whose loss in mice
affects the caudal, non–jaw-forming branchial arches.
This, together with the fact that branchial arch expression
ofHoxa2, as reported by Dobreva et al., is relativelynormal
in Satb2/ embryos, suggests that explanations for the
coordinated, focal jaw-related defects of the Satb2/ mu-
tants must extend beyond an interaction with Hoxa2 dur-
ing osteogenesis.
In search of mechanistic explanations for the observed
defects, both investigations assessed apoptotic cell death
in the branchial arches. Notably, Dobreva et al.28 found
increased cell death at E10.5 in the region of the maxillo-
mandibular junction, a region in which we failed to detect
Satb2 transcript at this same stage (ﬁg. 1b). A day later
(E11.5), however, we observed a marked increase in the
number of apoptotic cells in Satb2/ mutant embryos in
the mandibular and maxillary BA1 and FNP in those para-
sagittal regions where we also detected expression of Satb2
(ﬁgs. 1 and 5). Notably and in line with the observed
maintenance of midline structures, such as the rostral pro-
cess ofMeckel’s cartilage, themidlines are relatively spared
(ﬁg. 3). Thus, we ﬁnd that a partial explanation of the jaw
defects resides in the increased, coordinated, and localized
cell death that results from a loss of Satb2. This is coupled,
directly or indirectly, with changes in gene expression of
Alx4, Msx1, and Pax9, three genes known to be critical to
craniofacial development.
Moreover, the full functional loss of Satb2 results in an
ampliﬁcation of the defects found in Satb2/ mice, and
this revelation of Satb2-dosage sensitivity for craniofacial
development is conspicuous. Coupled with its control of
cell survival, its pattern of expression, and its reversible
functional posttranslational modiﬁcation by SUMOyla-
tion, this suggests that Satb2/SATB2 function in craniofa-
cial development may prove to be more profound than
has been anticipated previously, and its potentially crucial
signiﬁcance for understanding the complex etiology of
various craniofacial dysmorphologies, such as CP, specif-
ically and of craniofacial development and evolution in
general should not be overlooked.
Jaws are fundamental, functional cranial units thatwere
patent factors in the diversiﬁcation and success of the
vertebrates. As mechanisms, jaws are composed of two
articulated, or hinged, appositional units for which de-
velopmental polarity and modularity are inherent char-
acteristics5 (ﬁg. 6). Functionality demands that the devel-
opmental system that generates jaws be coordinated, to
keep these appositional units in register while elaborating
the morphology necessary to meet the speciﬁc demands
of an organism—for instance, it must result in the appro-
priately matched occlusion of the teeth in the upper and
lower jaws (ﬁg. 6b). This system is known to involve a
highly regulated series of inductive and responsive inter-
actions between the BA1 and FNP epithelia and subjacent
ectomesenchyme.1–4 The functional registration of jaws is
thought to be manifested through the integration of po-
sitional information stemming from distinct signaling
centers located at the junction of maxillary and mandib-
ular BA1 (including the pharyngeal plate) with that from
the most-distal BA1 midline and the lambdoidal junction
where themaxillary BA1meets the FNP. These centers thus
generate a system of polarity and modularity along the
axes of the developing craniofacial primordia (ﬁg. 6c–6e).
We have identiﬁed Satb2 as a key regulator of jaw and
palate development, where it controls cell survival in the
developmental modules in which it is expressed. With
respect to the polarity and potential modularity of the
jaws, Satb2 expression demarcates complementary do-
mains that are within the early-developing upper and
lower jaw primordia distad to the future jaw articulation
but that are signiﬁcantly excluded from the actual mid-
lines (ﬁgs. 1 and 6d). These domains are strategically
placed to act in the coordination of jaw registration by
coordinating the relative survival, within symmetrical
modules, of cell populations of fundamental importance
to the elaboration, registration, and coordination of the
upper and lower jaws. Because jaw development is Satb2-
dosage sensitive, the role of regulators of Satb2 expression
and posttranslational modiﬁcation reaches paramount
importance both ontogenetically and evolutionarily (ﬁg.
6f and 6g). Modiﬁcation of the Satb2/SATB2 regulatory
cascade leading to changes in cell survival can conceivably
play signiﬁcant yet underappreciated and possibly unde-
tected roles in jaw and palate development. We suggest
that Satb2 acts as an integral component of complemen-
tary developmental domains that will potentially beunder
their own selective pressures.
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